How to screen for diabetes risk in multi-ethnic populations: does one method fit all?

REFERENCES

• Lindstrom J, et al. Prevention of diabetes mellitus in subjects with impaired glucose tolerance in the Finnish diabetes prevention study: results from a randomized clinical trial. J Am Soc Nephrol 2003;14(7 Suppl 2):S108–13.
   Web of Science ®Google Scholar
• Knowler WC, et al Reduction in the inci-dence of type 2 diabetes with lifestyle inter-vention or metformin. N Engl J Med 2002; 346:393–403.
   PubMed Web of Science ®Google Scholar
• Tuomilehto J, et al Prevention of type 2 dia-betes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343–50.
   PubMed Web of Science ®Google Scholar
• Unwin N, et al Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002;19:708–23.
   PubMed Web of Science ®Google Scholar
• Abdul-Ghani MA, et al. Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose. Diabetes Care 2006;29:1613–8.
   PubMed Web of Science ®Google Scholar
• Stern MP, et al. Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med 2002;136: 575–81.
   PubMed Web of Science ®Google Scholar
• Aekplakorn W, et al. A risk score for predicting incident diabetes in the Thai populadon. Diabetes Care 2006;29:1872–7.
   Web of Science ®Google Scholar
• Wannamethee SG, et al. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 2005; 165:2644–50.
   PubMed Web of Science ®Google Scholar
• Kanaya AM, et al. Predicting the development of diabetes in older adults: the derivation and validation of a prediction rule. Diabetes Care 2005;28:404–8.
   PubMed Web of Science ®Google Scholar
• McNeely MJ, et al. Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 dia-betes risk in Japanese Americans. Diabetes Care 2003;26:758–63.
   Web of Science ®Google Scholar
• Gray LJ, et al. The Leicester Risk Assessment score for detecting undiagnosed type 2 dia-betes and impaired glucose regulation for use in a multiethnic UK setting. Diabet Med 2010;27:887–95.
   PubMed Web of Science ®Google Scholar
• Schwarz PE, et al. The Finnish Diabetes Risk Score is associated with insulin resistance and progression towards type 2 diabetes. J Clin Endocrinol Metab 2009;94:920–6.
   PubMed Web of Science ®Google Scholar
• Schulze MB, et al. An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes: response to Schwarz et al. Diabetes Care 2007;30:e88.
   Google Scholar
• Glumer, C, et al. A Danish diabetes risk score for targeted screening: the Inter99 study. Diabetes Care 2004;27:727–33.
   PubMed Web of Science ®Google Scholar
• Lindstrom J, Tuomilehto J. The Diabetes Risk Score: a practical tool to predict type 2 diabetes risk. Diabetes Care 2003;26:725–31.
   PubMed Web of Science ®Google Scholar
• Schwarz PE, et al. Tools for predicting the risk of type 2 diabetes in daily practice. Horm Metab Res 2009;41:86–97.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association, Inter-national Expert Committee report on the role of the Ali assay in the diagnosis of dia-betes. Diabetes Care 2009;32:1327–34.
   Web of Science ®Google Scholar
• Gillies CL, et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glu-cose tolerance: systematic review and meta-analysis. BMJ 2007;334 ( 7588) :299.
   PubMed Web of Science ®Google Scholar
• Abdul-Ghani MA, et al. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tol-erance and impaired fasting glucose. Diabetes Care 2006;29:1130–9.
   PubMed Web of Science ®Google Scholar
• Valensi P, et al. Pre-diabetes essential action: a European perspective. Diabetes Metab 2005; 31:606–20.
   PubMed Web of Science ®Google Scholar
• Schwarz PE, Lindstrom J. From evidence to practice - the IMAGE project - new stan-dards in the prevention of type 2 diabetes. Diabetes Res Clin Pract 2011;91:138–40.
   Web of Science ®Google Scholar
• Paulweber B, et al. A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res 2010;42 (Suppl 1):S3–S36.
   Google Scholar
• Lindstrom J, et al. Take action to prevent dia-betes - the IMAGE toolkit for the prevention of type 2 diabetes in Europe. Horm Metab Res 2010;42(Suppl 1):537–55.
   Google Scholar
• National Institute for Health and Clinical Excellence. NICE public health guidance 35: Preventing type 2 diabetes: population and community-level interventions in high-risk groups and the general population. London: NICE, 2011.
   Google Scholar
• Griffin SJ, et al. Effect of early intensive mul-dfactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. Lancet 2011;378:156–67.
   PubMed Web of Science ®Google Scholar
• Franciosi M, et al. Use of the diabetes risk score for opportunistic screening of undiag-nosed diabetes and impaired glucose toler-ance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study. Diabetes Care 2005; 28:1187–94.
   PubMed Web of Science ®Google Scholar
• Rathmann W, et al. Performance of screen-ing questionnaires and risk scores for undi-agnosed diabetes: the KORA Survey 2000. Arch Intern Med 2005;165:436–41.
   PubMed Web of Science ®Google Scholar
• Glumer CK, et al. Can a screening pro-gramme for diabetes be applied to another population? Diabet Med 2005;22:1234–8.
   Web of Science ®Google Scholar
• Mohan V, et al. A diabetes risk score helps identify metabolic syndrome and cardiovas-cular risk in Indians - the Chennai Urban Rural Epidemiology Study (CURES-38). Diabetes Obes Metab 2007;9:337–43.
   Web of Science ®Google Scholar
• Park PJ, et al. The performance of a risk score in predicting undiagnosed hyper-glycemia. Diabetes Care 2002;25:984–8.
   PubMed Web of Science ®Google Scholar
• Hippisley-Cox, J, et al. Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. BMJ2009; 338: b880.
   Google Scholar
• Taub NA, et al. Automated detection of high risk for impaired glucose regulation and type 2 diabetes mellitus, using primary care electronic data, in a multi-ethnic UK community setting. Diabetologia 2009; 52 (Suppl 1):S325–S326.
   Google Scholar
• Bluher S, et al. Who should we target for dia-betes prevention and diabetes risk reduction? Curr Diab Rep 2012;12: 147–56.
   Google Scholar
• Lee CM, Colagiuri S. Risk scores for diabetes prediction: The International Diabetes Federation PREDICT-2 project. Diabetes Res Clin Prad 2013;100:285–6.
   Web of Science ®Google Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33 (Suppl 1):S62–9.
   PubMed Web of Science ®Google Scholar
• Abdul-Ghani MA, et al. Role of glycated hemoglobin in the prediction of future risk of T2DM. J Clin Endocrinol Metab 2011;96: 2596–600.
   Web of Science ®Google Scholar
• Skriver MV, et al. HbAli as predictor of all-cause mortality in individuals at high risk of diabetes with normal glucose tolerance, identified by screening: a follow-up study of the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION), Denmark. Diabetologia 2011;53:2328–33.
   Web of Science ®Google Scholar
• Zhang X, et al. Ali level and future risk of diabetes: a systematic review. Diabetes Care 2010;33:1665–73.
   PubMed Web of Science ®Google Scholar
• Lorenzo C, et al. Ak between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Care 2010;33:2104–9.
   PubMed Web of Science ®Google Scholar
• Hawleyi Exercise as a therapeutic interven-tion for the prevention and treatment of insulin resistance. Diabetes Metab Res Rev 2004;20:383–93.
   Web of Science ®Google Scholar
• Bassuk SS, Manson JE. Epidemiological evidence for the role of physical activity in reduc-ing risk of type 2 diabetes and cardiovascular disease. Appi Physiol 2005;99:1193–204.
   PubMed Web of Science ®Google Scholar
• Telford RD. Low physical activity and obesity: causes of chronic disease or simply pre-dictors? Med Sci Sports Exerc 2007;39:1233–40.
   PubMed Web of Science ®Google Scholar
• Sisson SB, Katzmarzyk PT. International prevalence of physical activity in youth and adults. Obes Rev 2008;9:606–14.
   PubMed Web of Science ®Google Scholar
• Carlson SA, et al. Trend and prevalence esti-mates based on the 2008 Physical Activity Guidelines for Americans. Am J Prey Med 2010;39:305–13.
   PubMed Web of Science ®Google Scholar
• NHS Information Centre. Health survey for England - 2008: physical activity and fitness. 2009. www.ic.nhs.uk/statistics-and-data-collections/health-and-lifestyles-related-surveys/health-survey-for-england/health-survey-for-england-2008-physical-activity-and-fitness.
   Google Scholar
• Troiano RP et al. Physical activity in the United States measured by accelerometer. Med Sci Sports Exerc 2008;40:181–8.
   PubMed Web of Science ®Google Scholar
• Schwarz PE, et al. Nonpharmacological interventions for the prevention of type 2 diabetes mellitus. Nat Rev Endocrinol 2012; 8:363–73.
   PubMed Web of Science ®Google Scholar
• Gill JM, et al. Sitting time and waist circum-ference are associated with glycemia in U.K. South Asians: data from 1,228 adults screened for the PODOSA trial. Diabetes Care 2011;34:1214–8.
   PubMed Web of Science ®Google Scholar
• Whitlock G, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective stud-ies. Lancet 2009;373 (9669) :1083–96.
   PubMed Web of Science ®Google Scholar
• Thamer C, et al. High visceral fat mass and high liver fat are associated with resistance to lifestyle intervention. Obesity (Silver Spring) 2007;15:531–8.
   PubMed Web of Science ®Google Scholar
• Salopuro TM, et al. Population-level effects of the national diabetes prevention pro-gramme (FIN-D2D) on the body weight, the waist circumference, and the prevalence of obesity. BMC Public Health 2011;11:350.
   PubMed Web of Science ®Google Scholar
• Gillies CL, et al. Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ 2008;336(7654):1180–5.
   PubMed Web of Science ®Google Scholar
• Gillett M, et al. Delivering the diabetes edu-cation and self management for ongoing and newly diagnosed (DESMOND) pro-gramme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis. BMJ2010;341:c4093.
   PubMed Web of Science ®Google Scholar
• Bethel MA, et al. Evaluation of a self-admin-istered oral glucose tolerance test. Diabetes Care 2013;36:1483–8.
   Web of Science ®Google Scholar
• Yates T, et al. Effect of physical activity meas-urement type on the association between walking activity and glucose regulation in a high-risk population recruited from primary care. Int J Epidemiol 2013;42:533–40.
   Web of Science ®Google Scholar
• Schwarz PE, Albright AL. Prevention of type 2 diabetes: the strategic approach for imple-mentation. Horm Metab Res 2011;43:907–10.
   PubMed Web of Science ®Google Scholar
• Sodjinou R, et al. Obesity and cardio-meta-bolic risk factors in urban adults of Benin: relationship with socio-economic status, urbanisation, and lifestyle patterns. BMC Public Health 2008;8:84.
   PubMed Web of Science ®Google Scholar
• Zampetaki A, et al. Plasma microRNA profil-ing reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 2010;107:810–7.
   PubMed Web of Science ®Google Scholar